APA (7th ed.) Citation

R, R., R, O., P, H. C., O, S. M., MDC, P., M, B., . . . L, V. (2022). Erythropoietin in Spinocerebellar Ataxia Type 2: Feasibility and Proof-of-Principle Issues from a Randomized Controlled Study. Movement disorders : official journal of the Movement Disorder Society, 37(7), 1516. https://doi.org/10.1002/mds.29045

Chicago Style (17th ed.) Citation

R, Rodriguez-Labrada, et al. "Erythropoietin in Spinocerebellar Ataxia Type 2: Feasibility and Proof-of-Principle Issues from a Randomized Controlled Study." Movement Disorders : Official Journal of the Movement Disorder Society 37, no. 7 (2022): 1516. https://doi.org/10.1002/mds.29045.

MLA (9th ed.) Citation

R, Rodriguez-Labrada, et al. "Erythropoietin in Spinocerebellar Ataxia Type 2: Feasibility and Proof-of-Principle Issues from a Randomized Controlled Study." Movement Disorders : Official Journal of the Movement Disorder Society, vol. 37, no. 7, 2022, p. 1516, https://doi.org/10.1002/mds.29045.